These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19778662)

  • 21. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of peripheral arterial disease in chronic kidney disease.
    O'Hare AM
    Cardiol Clin; 2005 Aug; 23(3):225-36. PubMed ID: 16084274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
    McDermott MM; Ferrucci L; Liu K; Criqui MH; Greenland P; Green D; Guralnik JM; Ridker PM; Taylor LM; Rifai N; Tian L; Zheng J; Pearce WH; Schneider JR; Vonesh E
    J Am Geriatr Soc; 2005 Oct; 53(10):1688-96. PubMed ID: 16181167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does lower-extremity arterial disease predict future falling among older men and women?
    Arseven A; Guralnik JM; O'Brien Kaleba E; Liu K; Chan C; McDermott MM
    Angiology; 2007 Dec-2008 Jan; 58(6):725-33. PubMed ID: 18071192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral artery disease: therapeutic advances.
    Shamoun F; Sural N; Abela G
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):539-53. PubMed ID: 18402543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb.
    Brevetti G; Colao A; Schiano V; Pivonello R; Laurenzano E; Di Somma C; Lombardi G; Chiariello M
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):894-900. PubMed ID: 18410545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein (CRP) as a marker in peripheral vascular disease.
    Abdellaoui A; Al-Khaffaf H
    Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):18-22. PubMed ID: 17296319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral artery disease and genetics: is there a cause-and-effect relationship?
    Chi YW; Jaff MR
    Postgrad Med; 2010 Jul; 122(4):170-6. PubMed ID: 20675979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.
    Aguilar EM; Miralles Jde H; González AF; Casariego CV; Moreno SB; García FA
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):443-7. PubMed ID: 19211277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women and peripheral arterial disease: same disease, different issues.
    Brevetti G; Bucur R; Balbarini A; Melillo E; Novo S; Muratori I; Chiariello M
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):382-8. PubMed ID: 18334893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory circulating molecules in peripheral arterial disease.
    Signorelli SS; Mazzarino MC; Spandidos DA; Malaponte G
    Int J Mol Med; 2007 Sep; 20(3):279-86. PubMed ID: 17671730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?].
    Taute BM
    Hamostaseologie; 2006 Aug; 26(3):201-7. PubMed ID: 16906236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rational connection of inflammation with peripheral arterial disease.
    Li J; Li JJ; Li Q; Li Z; Qian HY
    Med Hypotheses; 2007; 69(6):1190-5. PubMed ID: 17555883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic association studies in peripheral arterial disease.
    Chi YW; Osinbowale O; Milani R
    J La State Med Soc; 2011; 163(1):30-4, 36-7, 39. PubMed ID: 21675004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.